3 Results for "

BIBX 1382

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BIBX 1382" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10322
CAS No.: 196612-93-8
Purity:  99.41%
Synonyms: BIBX 1382
Target:  

EGFR

Research Areas:  

Cancer

Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-110039
CAS No.: 1216920-18-1
Target:  

EGFR

Research Areas:  

Infection

BIBX 1382 dihydrochloride is an ErbB kinase inhibitor with significant antiviral activity. BIBX 1382 affects the ability of viruses to enter host cells by inhibiting members of the ErbB kinase family. It can be used to study the interaction mechanism between virus and host and the broad spectrum intervention of highly pathogenic viruses .
loading...
    loading...
Cat. No.: HY-10322R
CAS No.: 196612-93-8
Synonyms: BIBX 1382 (Standard)
Research Areas:  

Cancer

Falnidamol (Standard) is the analytical standard of Falnidamol. This product is intended for research and analytical applications. Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity .
loading...
    loading...